Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAN.A
926
DELISTED
AARON'S INC CL-A
AAN.A
| $7.39M | 0.01% |
129,400
+2,100
| +2% | +$120K |
|
927
Timken Company
TKR
$5.47B
| $7.38M | 0.01% |
131,000
+2,100
| +2% | +$118K |
|
|
CIM
928
Chimera Investment
CIM
$1.16B
| $7.37M | 0.01% |
119,427
+2,067
| +2% | +$127K |
|
929
First Hawaiian
FHB
$3.18B
| $7.36M | 0.01% |
255,167
+1,100
| +0.4% | +$31.7K |
|
930
Outfront Media
OUT
$3.12B
| $7.36M | 0.01% |
278,737
+8,026
| +3% | +$212K |
|
931
Mercury Systems
MRCY
$4.35B
| $7.33M | 0.01% |
106,100
+1,900
| +2% | +$131K |
|
|
WRI
932
DELISTED
Weingarten Realty Investors
WRI
| $7.31M | 0.01% |
234,000
+4,000
| +2% | +$125K |
|
933
Eagle Materials
EXP
$7.65B
| $7.29M | 0.01% |
80,400
-2,700
| -3% | -$245K |
|
934
SLM Corp
SLM
$5.98B
| $7.28M | 0.01% |
816,592
+3,100
| +0.4% | +$27.6K |
|
935
Nektar Therapeutics
NKTR
$893M
| $7.27M | 0.01% |
22,455
-15,920
| -41% | -$5.15M |
|
|
AUY
936
DELISTED
Yamana Gold, Inc.
AUY
| $7.22M | 0.01% |
1,825,200
+24,700
| +1% | +$97.7K |
|
937
Cinemark Holdings
CNK
$3.23B
| $7.21M | 0.01% |
213,100
+3,800
| +2% | +$129K |
|
938
ASGN Inc
ASGN
$2.3B
| $7.18M | 0.01% |
101,200
+1,800
| +2% | +$128K |
|
939
Choice Hotels
CHH
$5.29B
| $7.16M | 0.01% |
69,267
+1,300
| +2% | +$134K |
|
|
BPMC
940
DELISTED
Blueprint Medicines
BPMC
| $7.15M | 0.01% |
89,300
+1,900
| +2% | +$152K |
|
941
Ollie's Bargain Outlet
OLLI
$8.07B
| $7.14M | 0.01% |
109,300
+1,800
| +2% | +$118K |
|
|
SAGE
942
DELISTED
Sage Therapeutics
SAGE
| $7.13M | 0.01% |
98,800
+2,500
| +3% | +$180K |
|
943
Texas Roadhouse
TXRH
$11.1B
| $7.13M | 0.01% |
126,600
-1,800
| -1% | -$101K |
|
|
SYNH
944
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $7.07M | 0.01% |
118,877
+1,800
| +2% | +$107K |
|
945
ICU Medical
ICUI
$3.28B
| $7.04M | 0.01% |
37,619
+800
| +2% | +$150K |
|
946
Louisiana-Pacific
LPX
$6.76B
| $7.02M | 0.01% |
236,600
+4,300
| +2% | +$128K |
|
|
WMGI
947
DELISTED
Wright Medical Group Inc
WMGI
| $7.02M | 0.01% |
230,294
+4,800
| +2% | +$146K |
|
948
Community Bank
CBU
$3.11B
| $7M | 0.01% |
98,700
+1,700
| +2% | +$121K |
|
949
Ingevity
NGVT
$2.13B
| $7M | 0.01% |
80,090
+1,300
| +2% | +$114K |
|
950
LivaNova
LIVN
$3.11B
| $6.98M | 0.01% |
92,519
+1,500
| +2% | +$113K |
|